💻 Technology
Live
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Ars Technica — 6 August 2026
Text:
9
0
0
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
This report comes from Ars Technica. The story centres on Moderna's mRNA flu shot earns FDA approval after rollercoaster review. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from Ars Technica and related outlets covering this beat.
Read Full Story at Ars Technica → Sources
💻 Technology
Alonso pleased with Aston Martin upgrade as Newey targets 'respectability'
💻 Technology
Apple announces Silo’s season 4 return date
💻 Technology
Anthropic upgrades Claude with new Opus 5 model, details here
💻 Technology
New Macs are coming soon, here’s everything we know
💻 Technology
7 States’ Water Systems Hit by Cyberattacks Likely Tied to Iran
💻 Technology
Hanwha Group and LG CNS tokenize trade receivables to enhance supply chain finance
